The history of African trypanosomiasis
-
Correspondence: Dietmar Steverding dsteverding@hotmail.com
Parasites & Vectors 2008, 1:3 doi:10.1186/1756-3305-1-3
Accesses
- Last 30 days: 569 accesses
- Last year: 5154 accesses
- All time: 16607 accesses
Cited by
BioMed Central: 4 citations
|
Research article
Biochemical characterization of trans-sialidase TS1 variants from Trypanosoma congolense Hendrik Koliwer-Brandl, Thaddeus T Gbem, Mario Waespy, Olga Reichert, Philipp Mandel, Eric Drebitz, Frank Dietz, Sørge Kelm BMC Biochemistry 2011, 12:39 (30 July 2011) |
|
Review
The development of drugs for treatment of sleeping sickness: a historical review Dietmar Steverding Parasites & Vectors 2010, 3:15 (10 March 2010) This article is part of a collection on Historical aspects of... This review article outlines the development of anti-sleeping sickness drugs from the discovery of the first bioactive lead compounds to the identification of more modern chemotherapeutic agents. Image: Paul Ehrlich, pioneer in the development of drugs against trypanosomes.
|
|
Editorial
Bruce Kaplan, Laura H Kahn, Thomas P Monath, Jack Woodall Parasites & Vectors 2009, 2:36 (12 August 2009) One Health is the collaborative efforts of multiple disciplines working locally, nationally, and globally to attain optimal health for people, animals, plants and our environment. Image: Emerging and re-emerging infections - 70% vector-borne or zoonotic
|
|
Short report
Trypanocidal activity of the proteasome inhibitor and anti-cancer drug bortezomib Dietmar Steverding, Xia Wang Parasites & Vectors 2009, 2:29 (7 July 2009) Bortezomib (Velcade®) is the first therapeutic proteasome inhibitor for treatment of relapsed multiple myeloma and mantle cell lymphoma. The inhibitor is also very toxic to trypanosomes and may be useful for the treatment of sleeping sickness. Image:Structure of bortezomib (author Ben Mills.)
|